Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-versus-host Disease With Prednisone and Everolimus

NCT01862965 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Universitätsklinikum Hamburg-Eppendorf

Collaborators